Aperio Group’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
CS
Aperio Group's BLUE Position: Q4 2020 in Review
Aperio Group reduced its bluebird bio (BLUE) stake by 13% in Q4 2020, selling an estimated $259K and leaving 2,615 shares worth $1.47M. The position accounts for ﹤0.01% of the portfolio, ranked #1385.
Aperio Group first reported a position in BLUE in Q1 2015 and has held it in 21 quarters since. The position peaked at $2.11M in Q3 2020. 262 funds tracked by Wall St. Rank hold BLUE as of Q4 2020.
- Aperio Group held 2,615 shares of bluebird bio worth $1.47M as of Q4 2020.
- Aperio Group sold 408 bluebird bio shares in Q4 2020, an estimated $259K.
- bluebird bio made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #1385 holding.
- Aperio Group first reported a position in bluebird bio in Q1 2015 and has held it in 21 quarters since.
- Aperio Group's bluebird bio position peaked at $2.11M in Q3 2020.
- 262 funds tracked by Wall St. Rank held bluebird bio as of Q4 2020.
Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.